news 2020
« BACK
Pharmacology
Results 81 - 100 of 469.
Health - Pharmacology - 06.10.2020
Research suggests significantly less risk of COVID-19 transmission from anaesthesia procedures
Since the outset of the COVID-19 pandemic, there has been much debate about the danger to hospital staff from anaesthetic procedures. Concerns include that placing a tube in the patient's airway (intubation) before surgery or removing it at the end (extubation) may produce a fine mist of small particles (called aerosols) and spread the COVID-19 virus to nearby staff.
Health - Pharmacology - 06.10.2020
’COVID-19 free’ hospital areas could save lives after surgery - global study
Setting up 'COVID-19 free' hospital areas for surgical patients could save lives during the second wave of the pandemic - reducing the risk of death from lung infections associated with coronavirus, a new global study reveals. Researchers working together in Brazil and beyond found that that patients who had their operation and hospital care in 'COVID-19 free' areas had better outcomes.
Pharmacology - Health - 06.10.2020
Imaging technique could replace tissue biopsies in assessing drug resistance in breast cancer patients
Imaging techniques could replace the need for invasive tissue biopsies in helping rapidly determine whether cancer treatments are working effectively, according to researchers at the University of Cambridge. Currently, patients can wait a long time to find out if a treatment is working.
Pharmacology - Health - 06.10.2020
Colorectal cancer treatment: the winning combinations
A technique developed by scientists from the University of Geneva and HUG has made it possible to identify in vitro and validate in vivo, an optimised combination of anticancer drugs that are more effective than chemotherapy and that do not have side effects. A schematic drawing of colon and colorectal carcinoma.
Health - Pharmacology - 05.10.2020
Bristol part of new £4m FDA study to advance understanding of severe coronavirus infection
Bristol is part of a major new international project to improve our understanding of severe coronavirus infection in humans. The study, funded by the U.S. Food and Drug Administration (FDA), will analyse samples from humans and animals to create profiles of various coronaviruses, including SARS-CoV-2, which causes COVID-19.
Life Sciences - Pharmacology - 05.10.2020
Millimetre-precision drug delivery to the brain
Focused ultrasound waves help ETH researchers to deliver drugs to the brain with pinpoint accuracy, in other words only to where their effect is desired. This method is set to enable treatment of psychiatric and neurological disorders and tumours with fewer side effects in the future. Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy.
Pharmacology - Health - 01.10.2020
Expert opinion: COVID-19 vaccine rollout unlikely before fall 2021
Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published this week in the Journal of General Internal Medicine , a McGill-led team published the results of a recent survey of 28 experts working in vaccinology.
Health - Pharmacology - 30.09.2020
New research from Ticino on the antibody response to SARS-CoV-2
After the announcement, in May, of the first results of serological tests carried out on healthcare personnel in Ticino [ www.usi.ch/en/feeds/13622 ], significant data on the antibody response to SARS-CoV-2 is now available, thanks to the analysis carried out - among others - by the Institute for Research in Biomedicine (IRB, affiliated to USI) and Humabs BioMed (subsidiary of Vir Biotechnology), in close collaboration with hospitals and COVID-19 centers in Ticino (Ente Ospedaliero Cantonale EOC and Clinica Luganese Moncucco).
Health - Pharmacology - 28.09.2020
New technique for ultrafast tumour therapy
For the first time, researchers at the Centre for Proton Therapy at the Paul Scherrer Institute PSI in Switzerland have tested ultrafast, high-dose irradiation with protons. This new, experimental FLASH technique could revolutionise radiation therapy for cancer and save patients many weeks of treatment.
Health - Pharmacology - 28.09.2020
Researchers’ efforts to combat melanoma gets $13M boost from NIH
UCLA From left: Dr. Antoni Ribas, Thomas Graeber and Dr. Roger Lo, who have been collaborating on cancer research for more than a decade. UCLA researchers have received a $13 million grant from the National Institutes of Health to find new ways to overcome melanoma resistance to some of the most promising targeted therapies and immunotherapies.
Health - Pharmacology - 28.09.2020
Last-resort life support option helped majority of critically ill COVID-19 patients survive
It saved lives in past epidemics of lung-damaging viruses. Now, the life-support option known as ECMO appears to be doing the same for many of the critically ill COVID-19 patients who receive it, according to an international study led by a University of Michigan researcher. The 1,035 patients in the study faced a staggeringly high risk of death, as ventilators and other care failed to support their lungs.
Pharmacology - Health - 25.09.2020
Secure nano-carrier delivers medications directly to cells
Nanoparticles with synthetic DNA can control release of drugs Medications often have unwanted side-effects. One reason is that they reach not only the unhealthy cells for which they are intended, but also reach and have an impact on healthy cells. Researchers at the Technical University of Munich (TUM), working together with the KTH Royal Institute of Technology in Stockholm, have developed a stable nano-carrier for medications.
Health - Pharmacology - 24.09.2020
A fifth of people say they’re unlikely to get vaccinated against Covid-19
A fifth (22%) of people have said that when a Covid-19 vaccine is approved, they're unlikely to get it, with 10% of people saying they were 'very unlikely' to get vaccinated, find UCL researchers as part of the Covid-19 Social Study. Only half (49%) of people reported being 'very likely' to get vaccinated.
Pharmacology - Health - 23.09.2020
How machine learning can help to future-proof clinical trials in the era of COVID-19
The COVID-19 pandemic is the greatest global healthcare crisis of our generation, presenting enormous challenges to medical research, including clinical trials. Advances in machine learning are providing an opportunity to adapt clinical trials and lay the groundwork for smarter, faster and more flexible clinical trials in the future.
Health - Pharmacology - 22.09.2020
New vaccine strategy harnesses ’foot soldier’ T-cells to provide protection against influenza
As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza. In a study published in Cell Reports Medicine today (Sept.
Pharmacology - 21.09.2020
An acoustically actuated microscopic device
Researchers at EPFL have developed remote-controlled, mechanical microdevices that, when inserted into human tissue, can manipulate the fluid that surrounds them, collect cells or release drugs. This breakthrough offers numerous potential applications in the biomedical field, from diagnostics to therapy.
Health - Pharmacology - 21.09.2020
Giant spider provides promise of pain relief for irritable bowel syndrome
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS). Researchers screened 28 spiders, with the venom of the Venezuelan Pinkfoot Goliath tarantula - which has a leg-span of up to 30 centimetres - showing the most promise.
Health - Pharmacology - 18.09.2020
Increasing the effectiveness of immunotherapy against skin cancer
Researchers at the University of Bern have discovered a mechanism in the body's own immune system which is responsible for the maturing and activation of immune cells. In the fight against skin cancer, the results have the potential to help immunotherapy succeed, even for patients on whom it previously had no effect.
Pharmacology - Chemistry - 17.09.2020
Computational pharmacology ’made in USI’ scores again
Another important result for research in computational pharmacology "made in USI": Prof. Vittorio Limongelli of the Faculty of Biomedical Sciences and his PhD candidate Stefano Raniolo have developed a protocol that allows to simulate accurately the interaction between a drug and its molecular "target".
Health - Pharmacology - 15.09.2020
Only One Third of Children Receive Appropriate Malaria Care
Despite lots of progress made in the past decade, more than 270,000 children die from Malaria each year. Most of these deaths could be avoided through timely diagnosis and treatment. Despite better availability of tests and medication, a new study shows that large gaps remain in the quality of malaria care for children.
Advert